No Data
No Data
BioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
Express News | Shares of US-listed Chinese Companies Are Trading Higher After China's Central Bank Vowed to Take Measures to Support Its Real Estate and Shore up the Economy. Additionally, Alibaba Reported Better-than-expected Q3 Financial Results Which May Be...
BioAffinity Technologies Announces Australian Approval For Early-Stage Lung Cancer Detection Patent Via CyPath Lung Test; Patent Expiry in 2042; Strengthens Portfolio With 17 U.S. & Foreign Patents, 38 Applications Pending
BioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
BioAffinity Technologies Adjusts CEO Compensation Package
Express News | BioAffinity Technologies Announced CyPath Lung Beta Launch in Texas With 600+ Tests Sold in 2024